Search Results - FRENKEL, Eugene
-
1
Nanoparticles for drug delivery in cancer treatment
Published in Urologic oncology (2008)“…Abstract Nanoparticles (size in nanometer range) provide a new mode of cancer drug delivery functioning as a carrier for entry through fenestrations in tumor…”
Get full text
Journal Article -
2
Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients
Published in Neoplasia (New York, N.Y.) (01-10-2017)“…This is the first prospective study of the effects of human gut microbiota and metabolites on immune checkpoint inhibitor (ICT) response in metastatic melanoma…”
Get full text
Journal Article -
3
Microchip-based immunomagnetic detection of circulating tumor cells
Published in Lab on a chip (21-10-2011)“…Screening for circulating tumor cells (CTCs) in blood has been an object of interest for evidence of progressive disease, status of disease activity,…”
Get more information
Journal Article -
4
The paradoxical effect of bevacizumab in the therapy of malignant gliomas
Published in Neurology (04-01-2011)“…One rationale behind the use of agents that inhibit vascular endothelial growth factor in the therapy of primary CNS malignancies is based upon the concept…”
Get full text
Journal Article -
5
Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset
Published in Blood (04-04-2013)“…Mutations in the transcription factor GATA2 underlie the syndrome of monocytopenia and B- and natural killer (NK)-cell lymphopenia associated with…”
Get full text
Journal Article -
6
Versatile Immunomagnetic Nanocarrier Platform for Capturing Cancer Cells
Published in ACS nano (22-10-2013)“…Sensitive and quantitative assessment of changes in circulating tumor cells (CTCs) can help in cancer prognosis and in the evaluation of therapeutics efficacy…”
Get full text
Journal Article -
7
Circulating Tumor Cells in Patients with Breast Cancer Dormancy
Published in Clinical cancer research (15-12-2004)“…Purpose: The purpose of this study was to test the hypothesis that circulating tumor cells (CTCs) are present in patients many years after mastectomy without…”
Get full text
Journal Article -
8
Clopidogrel anti-platelet effect: An evaluation by optical aggregometry, impedance aggregometry, and the Platelet Function Analyzer (PFA-100™)
Published in Platelets (Edinburgh) (01-01-2007)“…Platelet aggregation inhibition by clopidogrel may be suboptimal in 4-30% of patients. Traditionally, optical aggregometry is used to assess clopidogrel's…”
Get full text
Journal Article -
9
Analysis of Thrombophilia Test Ordering Practices at an Academic Center: A Proposal for Appropriate Testing to Reduce Harm and Cost
Published in PloS one (13-05-2016)“…Ideally, thrombophilia testing should be tailored to the type of thrombotic event without the influence of anticoagulation therapy or acute phase effects which…”
Get full text
Journal Article -
10
Using iron oxide nanoparticles to diagnose CNS inflammatory diseases and PCNSL
Published in Neurology (16-07-2013)“…OBJECTIVE:The study goal was to assess the benefits and potential limitations in the use of ultrasmall superparamagnetic iron oxide (USPIO) nanoparticles in…”
Get full text
Journal Article -
11
Low plasma 25(OH) vitamin D level is associated with increased risk of COVID‐19 infection: an Israeli population‐based study
Published in The FEBS journal (01-09-2020)“…Vitamin D deficiency is a worldwide pandemic. The aim of this study was to evaluate associations of plasma 25(OH)D levels with the likelihood of coronavirus…”
Get full text
Journal Article -
12
HER-2 Gene Amplification Can Be Acquired as Breast Cancer Progresses
Published in Proceedings of the National Academy of Sciences - PNAS (22-06-2004)“…Amplification and overexpression of the HER-2 oncogene in breast cancer is felt to be stable over the course of disease and concordant between primary tumor…”
Get full text
Journal Article -
13
Aberrant Promoter Methylation Profile of Prostate Cancers and Its Relationship to Clinicopathological Features
Published in Clinical cancer research (01-02-2002)“…Purpose: We investigated the aberrant methylation profile of prostate cancers and correlated the data with clinical findings. Experimental Design: Gene…”
Get full text
Journal Article -
14
Systematic siRNA Screen Unmasks NSCLC Growth Dependence by Palmitoyltransferase DHHC5
Published in Molecular cancer research (01-04-2015)“…Protein S-palmitoylation is a widespread and dynamic posttranslational modification that regulates protein-membrane interactions, protein-protein interactions,…”
Get full text
Journal Article -
15
Preclinical antitumor activity of S‐222611, an oral reversible tyrosine kinase inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor 2
Published in Cancer science (01-08-2014)“…Epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2) are validated molecular targets in cancer therapy. Dual blockade…”
Get full text
Journal Article -
16
Immunomagnetic nanoscreening of circulating tumor cells with a motion controlled microfluidic system
Published in Biomedical microdevices (01-08-2013)“…Combining the power of immunomagnetic assay and microfluidic microchip operations, we successfully detected rare CTCs from clinical blood samples. The…”
Get full text
Journal Article -
17
Hyperhomocysteinemia and thrombosis
Published in Hematology/oncology clinics of North America (01-02-2003)“…Homocysteine remains an enigmatic marker for vascular disease. Studies have shown hyperhomocysteinemia is a risk factor for VTE, cerebrovascular disease, and…”
Get more information
Journal Article -
18
Thrombosis and a hypercoagulable state in HIV-infected patients
Published in Clinical and applied thrombosis/hemostasis (01-07-2004)“…Human immunodeficiency virus infection is an illness with protean manifestations including hematological abnormalities. Thromboembolic complications in…”
Get more information
Journal Article -
19
Histone deacetylase inhibitor romidepsin enhances anti-tumor effect of erlotinib in non-small cell lung cancer (NSCLC) cell lines
Published in Journal of thoracic oncology (01-02-2009)“…Most epidermal growth factor receptor (EGFR) mutant non-small cell lung cancers (NSCLCs) are sensitive to EGFR tyrosine kinase inhibitors (TKIs) such as…”
Get more information
Journal Article -
20
Clear Cell Renal Cell Carcinoma Subtypes Identified by BAP1 and PBRM1 Expression
Published in The Journal of urology (01-01-2016)“…Purpose In clear cell renal cell carcinoma BAP1 and PBRM1 are 2 of the most commonly mutated genes (10% to 15% and 40% to 50%, respectively). We sought to…”
Get full text
Journal Article